Glucose Health, Inc. - New 2-Pack GLUCODOWN® Raspberry # 1 at Amazon

BENTONVILLE, Ark., Jan. 25, 2021 /PRNewswire/ -- New GLUCODOWN® 2-Pack Raspberry arrived at Amazon last week – and is already trending across Amazon.com as a # 1 New Release. Amazon affixes the # 1 New Release moniker to new products which are showing strong consumer interest in their category. 

From the time GLUCODOWN® first listed at Amazon in late 2018, unauthorized third-party sellers have enjoyed success re-selling GLUCODOWN®. Previously, on January 4, 2021, Glucose Health, Inc. (OTC: GLUC) ("Company") advised shareholders the Company intended re-capture the revenue now benefitting third-party sellers, by listing its own variety and double packs for sale at Amazon. In just three weeks, all flavors of GLUCODOWN® now have active 2-Pack listings available for sale on Amazon.

Amazon Inventory Restrictions

In response to burgeoning demand by consumers for online shopping, accelerated by the pandemic, Amazon imposed limits on shipments of inventory to its fulfillment centers from its seller partners, including Glucose Health, Inc. The restrictions significantly reduced both the size and frequency of shipments to Amazon to satisfy orders for GLUCODOWN®. The Company immediately appealed to Amazon, making the case the restrictions would inevitably result in GLUCODOWN® selling-out in just weeks.

Following GLUCODOWN® Lemon and then Raspberry selling out and an urgent appeal to Amazon's leadership team, the Company's inventory allotment at Amazon was substantially increased. 5,000+ containers have already shipped from the Company's Rogers, Arkansas logistics partner and are at various stages of receiving in Amazon's inventory system. Additionally, replenishment shipments to Amazon are now proceeding relatively normally – a shipment of more than 1,000 containers is being readied for picked up by Amazon later this week.

Despite many GLUCODOWN® items in sold-out status this month, the Company is advising shareholders that January 2021 Amazon revenues, nevertheless, have already reached $30,000 – a 133% increase over January 2020 revenues of $12,827 – with 7 selling days still remaining in this month.

Additionally, in response to Amazon's inventory restrictions, the Company greatly accelerated implementation of its e-commerce plans for glucodown.com, first announced on January 4, 2021. The Company is pleased to advise its merchant account and credit card, debit card and e-check payment processing gateways all went live this past Friday, January 22. For the first time, all GLUCODOWN® flavors are available for purchase directly from Glucose Health, Inc. Despite no prior announcement or advertising, multiple orders for GLUCODOWN® have already been processed through glucodown.com this last weekend. Website orders will be fulfilled via our Rogers, Arkansas logistics partner. 

About Glucose Health, Inc. (OTC: GLUC)

More than 100 million Americans are estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.^[2] Introduced in 2018 and manufactured by Glucose Health, Inc., the GLUCODOWN® brand has come to define an entirely new and distinct dietary supplement category – functional, diabetic friendly, beverages. By specializing in producing delicious and efficacious beverages nutritionally appropriate^[1] for the nation's 100+ million pre and Type-2 diabetics, GLUCODOWN® is uniquely and strongly positioned among all up and coming beverage companies in America. Glucose Health, Inc. is a publicly traded company with the ticker symbol OTC: GLUC.

For more GLUC news visit www.glucosehealthinc.com.
Like us on Facebook at www.facebook.com/glucodown.

^1. For citations visit www.glucodown.com/clinical-data.
^2. National Diabetes Statistics Review, 2020; Centers for Disease Control and Prevention, Department of Health and Human Services.

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and while Glucose Health, Inc. is not subject to the 1934 Securities and Exchange Act, contains forward-looking statements within the meaning Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential, "possible," "probable, "believes," "seeks," "may, "will, "should," "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

Logo - https://mma.prnewswire.com/media/1201843/GLUC_Logo.jpg

Contact:
Murray Fleming
Glucose Health, Inc.
[email protected]
+1 (479) 802-3827

SOURCE Glucose Health, Inc.

Related Links

https://glucosehealthinc.com